A few years ago, the Vidjil project was born from a simple ambition within our research consortium: to build a tool that truly met our real-world needs in bioinformatics.
Since then, the project has grown organically, driven by the passion and feedback of our community.
However, as the project expanded beyond its original scope, we eventually hit the limits of our initial model and the misalignment of our initial model with clinical requirements.
Today, we are proud to introduce Eviclona as the future of Vidjil. Still dedicated to research, source-available, and community-focused, Eviclona will be tailored to meet the rigorous demands of clinical and medical use.

Discover how Eviclona can help you analyze your data through our platform.
Eviclona will reinforce the platform to respond to medical regulatory requirements. In 2027, we will pass certification.


Patiently built over more than 10 years alongside our community of clinicians and researchers, our analysis page lets you seamlessly explore the data provided by your immune repertoire samples.
Enjoy seamless laboratory management of your data, organized by runs or sets. Upload samples and launch multiple workflows tailored to your case needs, sequencing methods, or protocols.

From the beginning, we built an algorithm capable of analyzing immune repertoires with speed and precision. It is the core of our platform and powers every analysis you rely on.
Enjoy a seamless development experience with a flexible platform that lets you build and run your own bioinformatics pipeline in a secure, open-core environment.


Contact us to help drive your research with the Eviclona platform or the Vidjil algorithm.
The platform will be refactored to support modular interfaces, plugins, workflows, and analysis tools.

Read testimonials from clinical and research teams using Vidjil.
Schedule a meeting with our team to prepare your administrative steps and ensure a seamless transition.